Dr. Makker on Synergy Between Lenvatinib and Pembrolizumab in Endometrial Cancer
3 Bekeken
administrator
09/30/23
Vicky Makker, MD, medical oncologist, Memorial Sloan Kettering Cancer Center, discusses the synergy between lenvatinib and pembrolizumab in the treatment of patients with endometrial cancer.
Laat meer zien
Facebook Reacties
Geen reacties gevonden